Clinical Trials Browser

Cholangiocarcinoma

Recurrence, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

Colorectal Neoplasms

Hodgkin Disease, Lymphoma, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse

Cervical Esophagus Adenocarcinoma

Carcinoma, Transitional Cell

Pancreatic Metastatic Cancer

Elderly Metastatic Colorectal Cancer Patients

Clinical Stage 0 Gastric Cancer AJCC v8

Borderline Resectable Pancreatic Adenocarcinoma

Stomach Neoplasms

Rectal Neoplasms

Biliary Tract Neoplasms

Stomach Neoplasms

Stomach Neoplasms

Pancreatic Neoplasms

Esophageal Neoplasms

Stomach Neoplasms

Adenocarcinoma Of Esophagus

Appendiceal Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Rectal Neoplasms, Stomach Neoplasms

Stomach Neoplasms

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

Colorectal Neoplasms

Locally Advanced Rectal Cancer

Pancreatic Neoplasms, Neoplasms, Basal Cell

Lymphoma, Large B-Cell, Diffuse

Locally Advanced Colorectal Cancer

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Rectal Neoplasms

Clinical Trials

Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

Study of Lacutamab in Peripheral T-cell Lymphoma

Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin

A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer

PAMELA70

COBRA

Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

T-DXd_HER2Low

Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer

Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer

An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib With Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients With Gastric Cancer

TOGAR

LAP100

LyRICX

A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/Gastroesophageal Junction Adenocarcinoma

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

Toco-CoR

TORCH-iTNT

PANGEA

Low Dose Epcoritamab Plus GemOx in R/R DLBCL

Umbrella Trial of Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer